Hide Board Information

Show Board Information

SOCIETE GENERALE ACCEPTANCE NV CALL WTS 13/11/15(FTSE 100 IDX)GBP0.001 SG92

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 2:03:30 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

SOCIETE GENERALE ACCEPTANCE NV CALL WTS 13/11/15(FTSE 100 IDX)GBP0.001 (SG92) Stock Message Board

Find SG92 Recent News, SG92 Filings, SG92 Stock Quote, SG92 Stock Chart, SG92 Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on SOCIETE GENERALE ACCEPTANCE NV CALL WTS 13/11/15(FTSE 100 IDX)GBP0.001 SG92

Recent Articles

• Understanding Man Group PLC's Securities Disclosure Framework
• Albion Technology & General's Equity Issue Announcement
• Fenix Outdoor Reports Impressive Growth in Quarter 3 Results
• Acorn Energy's Q3 Earnings Call Set to Showcase Growth Insights
• Latest Analyst Ratings Highlight Immuneering and More
• Vireo Growth Inc. Prepares for Q3 Results and Investor Call
• Cytokinetics Showcases Cutting-Edge Research at Key Conferences
• Corvus Pharmaceuticals Elevates Investor Engagement at Conference
• TG Therapeutics Announces Upcoming Conference Call for Q3 2025
• Creative Realities, Inc. Shares Exciting Q3 2025 Earnings News
• Corvus Pharmaceuticals Engages Investors at Healthcare Conference
• Cytokinetics to Present Novel Research at Major Heart Conferences
• Trading Suspension Updates for Premium Catering Holdings
• Vireo Growth Inc. Set to Announce Q3 Results and Insights
• Canadian National Railway Reports Strong Q3 Performance
• TG Therapeutics' Upcoming Conference Call to Discuss Q3 Results
• Birchtree Investments Completes Successful Fundraising Round
• Creative Realities' Upcoming Earnings Call: What to Expect
• RVC Zero Investment LP Deepens Portfolio with Edge Copper
• Stardust Power Achieves Nasdaq Compliance and Sets Growth Path
• CN Railway Announces Generous Fourth-Quarter Dividend Update
• Birchtree Investments Finalizes Private Placement Funding
• Clearmind Medicine's New Patent Aims to Combat Cocaine Dependence
• CN Approves Dividend for Shareholders in Q4 2025
• Exploring Undervalued Stocks in the Financial Sector
• Clearmind Medicine Secures Patent for Cocaine Addiction Therapy
• Oroco Resource Corp. Advancing Financing Initiatives
• Navigating AI Trends in Luxury Real Estate with REALM
• Agnico Eagle Achieves Record Q3 Results and New Ventures
• Arcos Unveils José Andrés Jamón Knife: A Culinary Masterpiece
• Canadian National Railway Reports Impressive Q3 Earnings Results
• Bermuda Strengthens Insurtech Presence at Major Conference
• Federal Realty Shows Strong Growth in Q3 Financial Results
• Federal Realty Investment Trust Shows Impressive Q3 Growth
• Trimble Partners with Liverpool FC to Shape the Future
• HoldCo Asset Management Engages with Eastern Bankshares Board
• AGCO's Latest Earnings Reveal Insights for Investors
• Meijer Amplifies Community Support with $4 Million Donation Drive
• Cboe Global Markets Sees Record Growth in 2025 Q3 Results
• Trimble Partners With Liverpool FC for Innovative Academy Project
• Sinopec and BASF Forge New Frontier in Carbon Footprint Standards
• Nvidia's Exclusive Deal with Taiwan Semiconductor for A16 Chip
• Mesa Air Group Reports Major Loan Amendment and Merger Progress
• Discover Upstream Bio's Investor Conference Schedule for November
• Amicus Therapeutics Announces Conference Participation for Investors
• Falco Resources Ltd. Extends Senior Debt Agreements
• Yangibana Joint Venture Collaborates with Ucore for Rare Earths
• Market Impact of Trump and Xi's Trade Truce on Chinese Stocks
• PTC Emerges as a Leader in 2025 Application Management Market
• Toyota and Nissan Explore U.S.-Made Car Imports to Japan